Parker Geoffrey M. 4
4 · Allogene Therapeutics, Inc. · Filed May 20, 2024
Insider Transaction Report
Form 4
Parker Geoffrey M.
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2024-05-16$2.90/sh+344,828$1,000,001→ 1,164,418 total
Footnotes (1)
- [F1]These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering.